Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IGM Biosciences Inc IGMS

Healthcare Biotechnology
IGM Biosciences, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing and delivering a new class of medicines to treat patients with cancer and autoimmune and inflammatory diseases. The Company’s pipeline of clinical and preclinical assets is based on the IgM antibody, which has 10 binding sites compared to conventional IgG antibodies with only two binding sites.... see more

Bullboard (NDAQ:IGMS)

View:
User Avatar Image
(275)
•••
  • whytestocksX
Post by whytestockson Nov 08, 2024 10:45pm

IGM Biosciences Announces Third Quarter 2024 Financial Resul

Just In: $IGMS IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update@ Imvotamab (CD20 x CD3) trials in rheumatoid arthritis, systemic lupus erythematosus and ...more  
40
User Avatar Image
(275)
•••
  • whytestocksX
Post by whytestockson Sep 30, 2024 11:17pm

IGM Biosciences Announces Strategic Pivot to Focus Exclusive

NEWS: $IGMS IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity@ Company to prioritize its pipeline of T cell engagers in autoimmune diseases, including ongoing clinical ...more  
487
User Avatar Image
(275)
•••
  • whytestocksX
Post by whytestockson Feb 01, 2024 5:00pm

IGM Biosciences to Present at the Guggenheim Healthcare Talk

BREAKING NEWS: $IGMS IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference | BenzingaMOUNTAIN VIEW, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IGM ...more  
57
User Avatar Image
(4)
•••
  • AviseAnalyticsX
Post by AviseAnalyticson Apr 01, 2022 9:07am

5 THINGS YOU MUST KNOW ABOUT IGM BIOSCIENCES!

$IGMS IGM Biosciences, Inc. (NASDAQ: IGMS) announced an exclusive worldwide collaboration agreement with Sanofi for developing and commercializing IgM antibody agonists against six initial targets ...more  
96
Post by Saaaa1on May 06, 2021 8:31pm

$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀

iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver, British Columbia - (Newsfile Corp. - April 20, 2021) - iMining ...more  
102